Hepatitis C News and Research

Latest Hepatitis C News and Research

Scientists are testing the effectiveness of a new type of flu vaccine

The experimental vaccine instead relies on a cell line drawn from insects known as silk moths, which are better known for their role as pests attacking crops such as corn, cotton, barley and alfalfa.

25 Oct 2004

Stable liquid technology will enable vaccines to be stored for long periods without refrigeration and reconstitution

A UK vaccine technology that is set to revolutionise the industry has received £950k funding from the Department for International Development (DFID) to bring to production a pentavalent childhood vaccine that can be stored without refrigeration.

25 Oct 2004

Hepatitis C infection increases likelihood of developing non-Hodgkin's lymphoma significantly

Patients infected with the hepatitis C virus (HCV) are six times as likely to develop non-Hodgkin's lymphoma (NHL) than individuals that are virus free, according to research presented at the Third Annual Frontiers in Cancer Prevention Research meeting.

18 Oct 2004

Malaria vaccine candidate looks extremely promising

In a proof-of-concept study published this week in The Lancet, researchers report that GlaxoSmithKline's RTS,S/AS02A malaria vaccine candidate protected a significant percentage of children against uncomplicated malaria, infection, and even severe forms of the disease for at least six months.

16 Oct 2004

Infections among injecting drug users are a growing public health concern in the UK

New figures published by the UK's Health Protection Agency show that infections among injecting drug users (IDUs) are a growing public health concern.

13 Oct 2004

Viruses from human sources occur in the La Crosse, Wisconsin municipal drinking water supply prior to its chlorination

Although the city's treated water meets or exceeds state and federal standards for drinking water, researchers and public health officials agree that more study is needed to pinpoint sources of the viruses and to determine if some viruses are surviving chlorination and making people sick with diarrhea and vomiting.

6 Oct 2004

One group of drugs that is effective in fighting HIV may also be promoting the death of sensory nerves in the skin

One group of drugs that is effective in fighting HIV may, paradoxically, also be promoting the death of sensory nerves in the skin, according to a study presented October 5, 2004, at the 129th annual meeting of the American Neurological Association in Toronto.

5 Oct 2004

Teva Pharmaceuticals granted final approval for Ribavirin capsules

Teva Pharmaceutical Industries has announced that the U.S. Food and Drug Administration has granted final approval for the Company’s ANDA for Ribavirin Capsules, 200 mg. Shipment of this product is expected to begin immediately.

5 Oct 2004

Bristol-Myers Squibb submits New Drug Application to the U.S. Food and Drug Administration for entecavir

Bristol-Myers Squibb has announced the submission of a New Drug Application to the U.S. Food and Drug Administration for entecavir, an investigational antiviral agent under development for the treatment of chronic Hepatitis B.

4 Oct 2004

Chiron grants a non-exclusive license to the German Red Cross

Chiron Corporation has announced that it has granted a non-exclusive license to the Blood Transfusion Centers of the German Red Cross (Blutspendediensten des Deutsche Rotes Kreuz, or DRK) for use of the company's HIV-1 and hepatitis C virus (HCV) technology for use in molecular probe "home brew" blood screening.

4 Oct 2004

Circulation of ‘disaster myths’ in Haiti could hinder appropriate disposal of bodies

Myths about the infectious disease threat posed by dead bodies could lead to insensitive and inappropriate treatment of victims’ bodies following the floods in Haiti, and need to be checked, according to a public health researcher who has studied the potential risks at length.

30 Sep 2004

New combination of drugs results in fewer incidences of rejection in liver transplant patients

“The big advantage [of this combination of drugs] is that the incidence of rejection is significantly decreased,” he says. “These results could change the standard of care for liver transplant recipients.”

23 Sep 2004

Research to halt the progress of chronic liver disease

A University of Queensland researcher is working to halt the progress of chronic liver disease, which affects a quarter of million Australians.

22 Sep 2004

Edible vaccine for HIV AIDS

Scientists from Novosibirsk are engaged in the development of an unusual vaccine which, apart from being less expensive to produce, safe and painless to administer, is also edible.

22 Sep 2004

New recommendations which will help pre-empt drinking water contamination

Ensuring drinking water is safe is a challenge in every part of the world, from water piped into people's homes, to rural wells and water provided to refugee camps in an emergency.

22 Sep 2004

NIH opens new hospital totally dedicated to clinical research

This new hospital totally dedicated to clinical research — research involving patients — is the most significant addition to the NIH campus in more than 50 years and provides a unique opportunity for scientists, clinicians, and patients to study and conquer both chronic and acute disease in the 21st century.

22 Sep 2004

Liver cancer, cirrhosis of the liver and other diseases related to hepatitis B infection will continue to increase

Liver cancer, cirrhosis of the liver and other diseases related to hepatitis B infection will continue to kill people in the prime of life and burden health systems with chronically sick people unless childhood immunization against hepatitis B is stepped up

20 Sep 2004

Urgent measures need to be taken to protect the public from contaminated blood transfusions

In the Western Pacific Region, transmission of HIV/AIDS and other infections such as hepatitis B and C through blood transfusion remains a serious threat. It is particularly acute in areas where prevalence of these diseases is high and access to safe blood is limited.

16 Sep 2004

Severe hepatitis C recurrence is more common in transplants from living donors

Hepatitis C recurs with severity more often in individuals who receive liver transplants from living donors compared with those who get transplants from cadavers, according to a new study published in the September 2004 issue of Hepatology.

9 Sep 2004

Long-term outcomes for liver transplantation due to hepatitis C

A new study on liver transplants necessitated by the hepatitis C virus (the most common indication for this type of transplant) found that long-term outcomes are similar to patients receiving transplants due to other diseases.

8 Sep 2004

Hepatitis C News and Research

Latest Hepatitis C News and Research

Scientists are testing the effectiveness of a new type of flu vaccine

Stable liquid technology will enable vaccines to be stored for long periods without refrigeration and reconstitution

Hepatitis C infection increases likelihood of developing non-Hodgkin's lymphoma significantly

Malaria vaccine candidate looks extremely promising

Infections among injecting drug users are a growing public health concern in the UK

Viruses from human sources occur in the La Crosse, Wisconsin municipal drinking water supply prior to its chlorination

One group of drugs that is effective in fighting HIV may also be promoting the death of sensory nerves in the skin

Teva Pharmaceuticals granted final approval for Ribavirin capsules

Bristol-Myers Squibb submits New Drug Application to the U.S. Food and Drug Administration for entecavir

Chiron grants a non-exclusive license to the German Red Cross

Circulation of ‘disaster myths’ in Haiti could hinder appropriate disposal of bodies

New combination of drugs results in fewer incidences of rejection in liver transplant patients

Research to halt the progress of chronic liver disease

Edible vaccine for HIV AIDS

New recommendations which will help pre-empt drinking water contamination

NIH opens new hospital totally dedicated to clinical research

Liver cancer, cirrhosis of the liver and other diseases related to hepatitis B infection will continue to increase

Urgent measures need to be taken to protect the public from contaminated blood transfusions

Severe hepatitis C recurrence is more common in transplants from living donors

Long-term outcomes for liver transplantation due to hepatitis C

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Hepatitis C News and Research

Latest Hepatitis C News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in